ORIGINAL RESEARCH article
Front. Immunol.
Sec. Systems Immunology
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1609183
This article is part of the Research TopicExploring the Applications of Artificial Intelligence in Disease Screening, Diagnosis, Treatment, and NursingView all 6 articles
CD79A and GADD45A as Novel Immune-Related Biomarkers for Respiratory Syncytial Virus Severity in Children: An Integrated Machine Learning Analysis and Clinical Validation
Provisionally accepted- 1Department of Pediatrics, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China
- 2Department of Urology, Affiliated Hospital of Youjiang Medical University of Nationalities, Baise, China
- 3Graduate School, Youjiang Medical College for Nationalities, Baise, China
- 4Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Region, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Respiratory syncytial virus (RSV) is a leading cause of severe lower respiratory infections in children, yet biomarkers for assessing disease severity remain limited. Herein, we investigated the differential expression biomarkers between RSV infected hospitalized patients, healthy groups and RSV infected outpatients.:Two publicly available transcriptomic datasets (GSE77087 and GSE188427) were retrieved from the Gene Expression Omnibus (GEO) database. The GSE77087 dataset comprised peripheral blood samples from 81 children with confirmed RSV infection (61 hospitalized and 20 outpatient) and 23 healthy controls. The GSE188427 dataset included 147 RSV-infected children (113 hospitalized and 34 outpatient) and 51 healthy controls. GO and KEGG pathway enrichment analyses were conducted on the intersecting DEGs via the clusterProfiler package, with terms deemed significant at FDR < 0.05.The CIBERSORT algorithm was applied to estimate the relative proportions of 22 immune cell types in 228 RSV-infected samples. Potential drug interactions for hug genes were predicted using the Drug-Gene Interaction Database (DGIdb). Competing endogenous RNA (ceRNA) networks were constructed using the SpongeScan database to identify lncRNAs interacting with the target miRNAs. Networks were visualized using Cytoscape (v3.10.1).Finally, Machine Learning-Based Biomarker Selection and hub gene identification and validation Results: Differential gene expression analysis revealed 81 overlapping genes between hospitalized and outpatient RSV-infected children. Machine learning models, particularly SVM (area under the curve, AUC = 0.950), prioritized CD79A and GADD45A as key predictors of hospitalization. CD79A was significantly downregulated in severe cases, correlating with impaired B-cell responses and cytotoxic immunity, while GADD45A, upregulated in severe infections, linked to oxidative stress and neutrophil-driven inflammation. Immune cell profiling highlighted distinct infiltration patterns, with severe cases showing elevated naïve B cells and M0 macrophages versus activated NK cells and M1 macrophages in mild cases. Clinical validation in 92 children confirmed CD79A suppression and GADD45A elevation in severe RSV (p < 0.001), aligning with younger age, lower weight, and respiratory distress. Functional enrichment implicated endoplasmic reticulum stress and neutrophil extracellular traps in disease progression. Drug-target predictions and ceRNA networks further revealed therapeutic potential.These findings establish CD79A and GADD45A as clinically actionable biomarkers for RSV severity, offering insights into immune dysregulation and guiding personalized management strategies.
Keywords: RSV, biomarkers, CD79A and GADD45A, machine learning, Severity assessment
Received: 10 Apr 2025; Accepted: 09 Jun 2025.
Copyright: © 2025 Chen, Lu, Jing, Lin, Nong, Qin, Wei and Huang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Jie Wei, Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Region, China
Jin Yang Huang, Department of Pediatrics, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.